chemXplore tracks 42 projects in Hungary, of which 8 are active.
Of the active ones, 5 new construction, 2 expansion and 1 conversion / repurposing.
1 active project carries no start-up date yet. The dates themselves, per project, are for subscribers.
Strong refining margins and higher gas prices lifted results, while petrochemicals weakness and regulated fuel pricing weighed on retail performance.
Unit restarted after nearly year-long repair following an Oct 20, 2025 fire; restoration cost ~18 billion HUF (USD 56M) and returned the unit to its original capacity, strengthening regional supply security.
PV Tech cites delivery record, over 3,000 deployed projects, >99% system reliability, >90% capacity utilisation and a new 100 GWh Hungary plant as reasons for AAA rating.
EU clears first PD‑1 inhibitor plus ADC regimen for resectable muscle‑invasive bladder cancer regardless of cisplatin eligibility; phase 3 showed EFS HR 0.53 and OS HR 0.65.
Built for more than HUF 2.7 billion, the Szarvas plant will produce >7 million m3/yr of pipeline‑quality biomethane—replacing gas for ~8,500 households—using regional meat and agricultural wastes.
CEO explains pivot from commodity trading to supply-chain integration, silo and feed investments, Maragro acquisition and recruitment ties to Cluj universities.
License extends negotiations to pursue a majority stake in Serbia's national oil firm through 30 Oct 2026.
New unit at Danube Refinery will double maleic anhydride output and is due online in H2 2027, aiming to strengthen European supply security and improve energy efficiency.
FDA clears once‑weekly basal insulin that reduces injection frequency vs daily therapy; Phase 3 QWINT trials in >3,400 adults showed non‑inferior A1C vs glargine and degludec.
Trial operations began 22 Sept 2026 in the new Debrecen cell factory, activating the first two production lines after occupancy and IPPC preconditions were met.
active / all projects
